Research confirms safety and efficacy of RemiFemin for menopausal symptoms

PITTSBURGH, March 25 - A study published in the current issue of The Journal of Women's Health and Gender-Based Medicine heralds good news for women who are looking for natural, estrogen-free options to relieve menopausal symptoms.

The study, conducted by Eckehard Liske, PhD and colleagues, shows that the commercially available dose of RemiFemin Menopause, an exclusive extract of black cohosh available over-the-counter, works differently from estrogens and plant estrogens to relieve menopausal symptoms.

"This data confirms that RemiFemin provides a safe and effective option for women who want to relieve menopause symptoms naturally," said Eckehard Liske, PhD, lead author of the study. "The product reduces menopause symptoms such as hot flashes, mood swings, night sweats and occasional sleeplessness without affecting hormone levels or specific cell lines associated with some female cancers."

In addition to examining the product's lack of estrogenic effect, the study compared the effectiveness and safety of two dosage forms of RemiFemin Menopause. After six months, the currently recommended daily dose (40 mg) showed similar benefits compared to a three-fold higher dose. Specifically, the study showed that the majority of women saw a 70% reduction in their physical and emotional menopausal symptoms when they took RemiFemin twice daily for 12 weeks. The results also show that doses above 40 mg per day do not demonstrate any significant therapeutic advantages nor does the higher dose result in a significantly greater number of side effects.

"These findings add to the large body of evidence that the currently available dose of RemiFemin Menopause results in statistically significant improvements in both physical and emotional menopausal symptoms in women," said Steven Weisman, PhD, a pharmacologist and herbal expert.

Study Design and Methods

This controlled, randomized, double blind, multi-center trial

Contact: Sarah Oetgen
Sensei Health

Page: 1 2 3

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Research offers hope of new treatments for liver damage
3. Research suggests possible blood test for multiple sclerosis
4. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
5. 2005 Award for Basic Research in Biological Mineralization
6. 2005 Craniofacial Biology Research Award
7. 2005 Research in Dental Caries Award
8. 2005 Research in Prosthodontics and Implants Award
9. 2005 Basic Research in Periodontal Disease Award
10. 2005 Research in Oral Biology Award
11. 2005 Pulp Biology Research Award

Post Your Comments:

(Date:4/19/2019)... ... April 19, 2019 , ... According to the Environmental Working ... comes with pesticide residue. Pesticides are sprayed on produce to repel insects, but they ... make up that thin, waxy layer that covers the skin of most produce foods ...
(Date:4/19/2019)... ... April 18, 2019 , ... Residents in long-term-care nursing facilities were ... This is according to a study of U.S. men and women led ... the Brandman Research Institute (BRI) . The quality assurance study examined the high ...
(Date:4/18/2019)... ... 18, 2019 , ... Catalent, a global leader in clinical ... Clinical Supplies Group (GCSG) 2019 US Annual Conference at the Hyatt Regency Hill ... 2019. , Erin Vlack, Project Manager, will present a workshop titled “Bridging the ...
(Date:4/18/2019)... Vt. (PRWEB) , ... April 18, 2019 , ... ... Vermont’s captive regulation in a variety of areas. This year’s bill proposed several ... and improvements to the statute governing group captive investments. The many enhancements included ...
(Date:4/18/2019)... ... April 18, 2019 , ... ... provider for their care. Through the rise of online review sites and healthcare-related ... interaction and transparency when making important purchasing decisions online. In order to elevate ...
Breaking Medicine News(10 mins):
(Date:4/17/2019)... ... 17, 2019 , ... Clinical trials of new cancer treatments have historically focused ... on. With advances in medical oncology and genomic characterization of tumors, we are now ... by conducting “basket trials.” This ability has created a paradigm shift in oncology trials. ...
(Date:4/17/2019)... MALDEN, Mass. (PRWEB) , ... April 17, 2019 ... ... Mark McFarland completed his 50th case using NanoFUSE Biologics. The operation took place ... Dr. McFarland performed a posterior lumbar interbody fusion and removal of hardware on ...
(Date:4/17/2019)... NEW YORK (PRWEB) , ... April 17, 2019 , ... ... Pink Bag Event® at Barclays Center on Wednesday, April 3rd. Barclays Center, ... of Brooklyn, NY. UBCF thanks Brett Yormark, CEO of BSE Global, which operates and ...
Breaking Medicine Technology:
Cached News: